Premium
This is an archive article published on November 7, 2009

Dr Reddy8217;s files for marketing Lipitor generic

Dr Reddy's Laboratories has filed for marketing a generic version of Pfizer's cholesterol-lowering drug Lipitor in the US,the company said on Saturday.

Dr Reddy8217;s Laboratories has filed for marketing a generic version of Pfizer8217;s cholesterol-lowering drug Lipitor in the US,the company said on Saturday.

8220;We have filed an ANDA abbreviated new drug filing for atrovastatin and notified Pfizer accordingly,8221; Dr Reddy8217;s told Reuters in response to an email query.

Earlier on Saturday,a business newspaper reported that Dr Reddy8217;s had developed a generic version for Lipitor,and along with its US subsidiary,had informed Pfizer about applying to the US Food and Drug Administration for marketing the drug.

Lipitor is the world8217;s largest selling drug,with global sales of 8.3 billion in the last nine months. So far,Ranbaxy is the only other Indian drugmaker to develop a generic for the drug,whose U.S. patent expires in 2010.

Under a settlement with Pfizer,Ranbaxy has agreed to launch its generic by November 2011.

 

Latest Comment
Post Comment
Read Comments
Advertisement
Advertisement
Advertisement
Advertisement